Question 1

Which Wall Street gurus hold Benitec Biopharma Inc (BNTC)?

Accepted Answer

Per the latest SEC 13F filings, 8 Wall Street gurus hold BNTC. Top holders include 드미트리 발야스니, 이스라엘 잉글랜더, 켄 그리핀, with a combined position value of about $34.3M.

Question 2

What sector does Benitec Biopharma Inc belong to?

Accepted Answer

Benitec Biopharma Inc (BNTC) is in the Biotechnology sector / Biotechnology industry, listed on NASDAQ NMS - GLOBAL MARKET.

Question 3

What are the key financial metrics for Benitec Biopharma Inc?

Accepted Answer

Key metrics for Benitec Biopharma Inc (BNTC): EPS $-1.11, Beta 0.29. Live price and chart are at the top of the page.

Question 4

What is a 13F report?

Accepted Answer

A 13F is a quarterly filing institutional investors submit to the US Securities and Exchange Commission (SEC) disclosing their equity holdings. It is mandatory for managers with at least $100M in AUM and must be filed within 45 days of the quarter end.

#	Investor	Weight	Shares	Value	Activity
1	Dmitry Balyasny Balyasny Asset Management LP	0.01%	653,835	$6.96M	HOLD
2	Israel Englander Millennium Management LLC	0.00%	652,064	$6.94M	HOLD
3	Ken Griffin Citadel Advisors LLC	0.00%	171,722	$1.83M	HOLD
4	Goldman Sachs Goldman Sachs Asset Management	0.00%	215,476	$2.29M	HOLD
5	BlackRock BlackRock Inc	0.00%	1,185,741	$12.63M	HOLD
6	State Street State Street Global Advisors	0.00%	338,249	$3.60M	HOLD
7	JPMorgan Chase JPMorgan Asset Management	0.00%	7,885	$79,323	HOLD
8	Fidelity (FMR) Fidelity Management & Research	0.00%	1,654	$17,615	HOLD

Benitec Biopharma Inc

Holders (8)

Related Articles (1)